Welcome to LookChem.com Sign In|Join Free
  • or
(3-fluoro-4-nitro-phenyl)-pyrrolidin-1-yl-methanone is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

552832-89-0

Post Buying Request

552832-89-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

552832-89-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 552832-89-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,2,8,3 and 2 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 552832-89:
(8*5)+(7*5)+(6*2)+(5*8)+(4*3)+(3*2)+(2*8)+(1*9)=170
170 % 10 = 0
So 552832-89-0 is a valid CAS Registry Number.

552832-89-0Relevant academic research and scientific papers

Discovery of 1-(3′-aminobenzisoxazol-5′-yl)-3-trifluoromethyl- N-[2-fluoro-4-[(2′-dimethylaminomethyl)imidazol-1-yl]phenyl] -1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor

Quan, Mimi L.,Lam, Patrick Y. S.,Han, Qi,Pinto, Donald J. P.,He, Ming Y.,Li, Renhua,Ellis, Christopher D.,Clark, Charles G.,Teleha, Christopher A.,Sun, Jung-Hui,Alexander, Richard S.,Bai, Steve,Luettgen, Joseph M.,Knabb, Robert M.,Wong, Pancras C.,Wexler, Ruth R.

, p. 1729 - 1744 (2007/10/03)

Modification of a series of pyrazole factor Xa inhibitors to incorporate an aminobenzisoxazole as the P1 ligand resulted in compounds with improved selectivity for factor Xa relative to trypsin and plasma kallikrein. Further optimization of the P4 moiety led to compounds with enhanced permeability and reduced protein binding. The SAR and pharmacokinetic profile of this series of compounds is described herein. These efforts culminated in 1-(3′-aminobenzisoxazol-5′-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2′-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide (11d), a potent, selective, and orally bioavailable inhibitor of factor Xa. On the basis of its excellent in vitro potency and selectivity profile, high free fraction in human plasma, good oral bioavailability, and in vivo efficacy in antithrombotic models, the HCl salt of this compound was selected for clinical development as razaxaban (DPC 906, BMS-561389).

Nonbenzamidine tetrazole derivatives as factor Xa inhibitors

Quan, Mimi L.,Ellis, Christopher D.,He, Ming Y.,Liauw, Ann Y.,Woerner, Francis J.,Alexander, Richard S.,Knabb, Robert M.,Lam, Patrick Y. S.,Luettgen, Joseph M.,Wong, Pancras C.,Wright, Matthew R.,Wexler, Ruth R.

, p. 369 - 373 (2007/10/03)

Factor Xa (fXa) is an important serine protease that holds the central position linking the intrinsic and extrinsic activation mechanisms in the blood coagulation cascade. Therefore, inhibition of fXa has potential therapeutic applications in the treatmen

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 552832-89-0